-
公开(公告)号:IL297706A
公开(公告)日:2022-12-01
申请号:IL29770622
申请日:2022-10-27
Applicant: BIOPROJET PHARMA , LECOMTE JEANNE MARIE , SCHWARTZ JEAN CHARLES , BERREBI BERTRAND ISABELLE , KRIEF ST?PHANE , LIGNEAU XAVIER , LECOMTE ISABELLE
Inventor: LECOMTE JEANNE-MARIE , SCHWARTZ JEAN CHARLES , BERREBI-BERTRAND ISABELLE , KRIEF ST?PHANE , LIGNEAU XAVIER , LECOMTE ISABELLE
IPC: A61K31/495
Abstract: The present invention provides for the use of D3 partial agonists for treating or inhibiting the restless leg syndrome (RLS) and neurodegenerative diseases, in particular D3 partial agonists/D2 antagonists.
-
2.CARBONYLATED (AZA) CYCLOHEXANES AS DOPAMINE D3 RECEPTOR LIGANDS 审中-公开
Title translation: 作为DOPAMINE D3受体配体的羰基化(AZA)环己酮公开(公告)号:WO2007148208A3
公开(公告)日:2008-06-12
申请号:PCT/IB2007001673
申请日:2007-06-21
Applicant: BIOPROJET SOC CIV , CAPET MARC , DANVY DENIS , LEVOIN NICOLAS , BERREBI-BERTRAND ISABELLE , CALMELS THIERRY , ROBERT PHILIPPE , LECOMTE JEANNE-MARIE , SCHWARTZ JEAN-CHARLES , LIGNEAU XAVIER
Inventor: CAPET MARC , DANVY DENIS , LEVOIN NICOLAS , BERREBI-BERTRAND ISABELLE , CALMELS THIERRY , ROBERT PHILIPPE , LECOMTE JEANNE-MARIE , SCHWARTZ JEAN-CHARLES , LIGNEAU XAVIER
IPC: C07D295/12 , A61K31/495 , A61P25/00 , C07D211/26 , C07D211/60 , C07D211/70 , C07D213/74 , C07D215/40 , C07D217/02 , C07D239/42 , C07D295/10 , C07D295/14 , C07D307/24
CPC classification number: C07D213/74 , C07D211/26 , C07D211/60 , C07D211/70 , C07D215/40 , C07D217/02 , C07D239/42 , C07D295/10 , C07D295/112 , C07D295/135 , C07D295/14 , C07D295/155 , C07D307/24
Abstract: The invention relates to compounds of the general formula (I): to the process for preparing them, and to the use thereof as a therapeutic agent.
Abstract translation: 本发明涉及通式(I)的化合物:其制备方法及其作为治疗剂的用途。
-
3.NEW CARBONYLATED (AZA)CYCLOHEXANES AS DOPAMINE D3 RECEPTOR LIGANDS 审中-公开
Title translation: 新戊酰胺(AZA)环己酮作为DOPAMINE D3受体配体公开(公告)号:WO2007148208A2
公开(公告)日:2007-12-27
申请号:PCT/IB2007/001673
申请日:2007-06-21
Applicant: BIOPROJET , CAPET, Marc , DANVY, Denis , LEVOIN, Nicolas , BERREBI-BERTRAND, Isabelle , CALMELS, Thierry , ROBERT, Philippe , LECOMTE, Jeanne-Marie , SCHWARTZ, Jean-Charles , LIGNEAU, Xavier
Inventor: CAPET, Marc , DANVY, Denis , LEVOIN, Nicolas , BERREBI-BERTRAND, Isabelle , CALMELS, Thierry , ROBERT, Philippe , LECOMTE, Jeanne-Marie , SCHWARTZ, Jean-Charles , LIGNEAU, Xavier
IPC: C07D295/12 , A61K31/495 , A61P25/00 , C07D211/26 , C07D295/14 , C07D295/10 , C07D307/24 , C07D211/70 , C07D211/60 , C07D213/74 , C07D217/02 , C07D239/42 , C07D215/40
CPC classification number: C07D213/74 , C07D211/26 , C07D211/60 , C07D211/70 , C07D215/40 , C07D217/02 , C07D239/42 , C07D295/10 , C07D295/112 , C07D295/135 , C07D295/14 , C07D295/155 , C07D307/24
Abstract: The invention relates to compounds of the general formula (I): to the process for preparing them, and to the use thereof as a therapeutic agent.
Abstract translation: 本发明涉及通式(I)的化合物:其制备方法及其作为治疗剂的用途。
-
4.NOVEL HISTAMINE H3-RECEPTOR LIGANDS AND THEIR THERAPEUTIC APPLICATIONS 审中-公开
Title translation: 新型组胺H3受体配体及其治疗应用公开(公告)号:WO2006117609A2
公开(公告)日:2006-11-09
申请号:PCT/IB2006/000991
申请日:2006-04-25
Applicant: BIOPROJET , BERTRAND, Isabelle , CAPET, Marc , LECOMTE, Jeanne-Marie , LEVOIN, Nicolas , LIGNEAU, Xavier , POUPARDIN-OLIVIER, Olivia , ROBERT, Philippe , SCHWARTZ, Jean-Charles , LABEEUW, Olivier
Inventor: BERTRAND, Isabelle , CAPET, Marc , LECOMTE, Jeanne-Marie , LEVOIN, Nicolas , LIGNEAU, Xavier , POUPARDIN-OLIVIER, Olivia , ROBERT, Philippe , SCHWARTZ, Jean-Charles , LABEEUW, Olivier
IPC: C07D295/088 , C07D213/30 , C07D211/68 , C07D333/16 , C07D211/14 , C07D401/10 , A61K31/40 , A61K31/44 , A61K31/381 , A61K31/5377
CPC classification number: C07D213/30 , C07D207/20 , C07D207/30 , C07D207/335 , C07D211/22 , C07D211/42 , C07D211/46 , C07D211/68 , C07D211/70 , C07D213/61 , C07D213/64 , C07D213/89 , C07D231/12 , C07D295/088 , C07D295/192 , C07D333/16 , C07D333/20 , C07D401/12 , C07D401/14 , C07D409/12 , C07D413/12
Abstract: The present patent application concerns new compounds of formula (I), their process of preparation and their therapeutic use.
Abstract translation: 本专利申请涉及式(I)的新化合物,其制备方法及其治疗用途。
-
公开(公告)号:WO2006079870A1
公开(公告)日:2006-08-03
申请号:PCT/IB2005/000446
申请日:2005-01-31
Applicant: FREESCALE SEMICONDUCTOR, INC , RENAUD, Philippe , BERTRAND, Isabelle
Inventor: RENAUD, Philippe , BERTRAND, Isabelle
IPC: B81C1/00 , H01L21/20 , H01L21/762
CPC classification number: B81C1/00611 , B81C2201/0119 , H01L21/02381 , H01L21/02488 , H01L21/02494 , H01L21/02532 , H01L21/02658 , H01L21/02667
Abstract: In the field of sensor fabrication, it is known to form a silicon-on-insulator starting structure from which fabrication of the sensor based. The present invention provides a method of forming a silicon-on-insulator structure comprising a substrate (102) having an insulating layer (104) patterned thereon. A silicon oxide layer (106) is then deposited over the patterned insulating layer (104) before silicon is grown over both an exposed surface of the substrate (102) as well as the silicon oxide layer (106), mono-crystalline silicon (108) forming on the exposed parts of the substrate (102) and polysilicon (110) forming on the silicon oxide layer (106). After depositing a capping layer 112 over the structure, the wafer is heated, whereby the polysilicon (110) re-crystallises to form mono-crystalline silicon (108), resulting in the insulating layer 104 being buried beneath mono-crystalline silicon.
Abstract translation: 在传感器制造领域中,已知形成绝缘体上硅开始结构,从而制造基于传感器的开关结构。 本发明提供一种形成绝缘体上硅结构的方法,其包括在其上图案化的绝缘层(104)的衬底(102)。 然后在硅在衬底(102)的暴露表面以及氧化硅层(106),单晶硅(108)之上生长硅之前,在图案化的绝缘层(104)上沉积氧化硅层(106) )形成在形成在氧化硅层(106)上的衬底(102)和多晶硅(110)的暴露部分上。 在结构上沉积覆盖层112之后,加热晶片,由此多晶硅(110)重新结晶以形成单晶硅(108),导致绝缘层104被埋在单晶硅之下。
-
6.NOVEL PHARMACEUTICALLY ACCEPTABLE SALTS OF 4-(1H-IMIDAZOL-4-YLMETHYL)PYRIDINE AND THEIR THERAPEUTICAL USES 审中-公开
Title translation: 4-(1H-咪唑-4-基)甲基吡啶的新药物接受量及其治疗用途公开(公告)号:WO2010133598A1
公开(公告)日:2010-11-25
申请号:PCT/EP2010/056824
申请日:2010-05-18
Applicant: BIOPROJET , CAPET, Marc , LABEEUW, Olivier , BERREBI-BERTRAND, Isabelle , ROBERT, Philippe , LIGNEAU, Xavier , LECOMTE, Jeanne-Marie , SCHWARTZ, Jean-Charles
Inventor: CAPET, Marc , LABEEUW, Olivier , BERREBI-BERTRAND, Isabelle , ROBERT, Philippe , LIGNEAU, Xavier , LECOMTE, Jeanne-Marie , SCHWARTZ, Jean-Charles
IPC: A61K31/4439 , C07D401/06 , A61P25/00
CPC classification number: A61K31/4439
Abstract: The present invention concerns novel pharmaceutical compositions of immethridine, in particular of novel pharmaceutically acceptable salts thereof, such as the dioxalate salt of immethridine, as well as its therapeutical uses and novel process of preparation.
Abstract translation: 本发明涉及新马来酰亚胺的药物组合物,特别是其新颖的药学上可接受的盐,例如异月桂胺的二恶烷盐,以及其治疗用途和新的制备方法。
-
7.PHENOXYPROPYLPIPERIDINES AND -PYRROLIDINES AND THEIR USE AS HISTAMINE H3 -RECEPTOR LIGANDS 审中-公开
Title translation: 苯氧基丙酸酯和吡咯烷酮及其作为组胺H3的抗原配体公开(公告)号:WO2006117609A3
公开(公告)日:2007-03-22
申请号:PCT/IB2006000991
申请日:2006-04-25
Applicant: BIOPROJET SOC CIV , BERTRAND ISABELLE , CAPET MARC , LECOMTE JEANNE-MARIE , LEVOIN NICOLAS , LIGNEAU XAVIER , POUPARDIN-OLIVIER OLIVIA , ROBERT PHILIPPE , SCHWARTZ JEAN-CHARLES , LABEEUW OLIVIER
Inventor: BERTRAND ISABELLE , CAPET MARC , LECOMTE JEANNE-MARIE , LEVOIN NICOLAS , LIGNEAU XAVIER , POUPARDIN-OLIVIER OLIVIA , ROBERT PHILIPPE , SCHWARTZ JEAN-CHARLES , LABEEUW OLIVIER
IPC: C07D295/088 , A61K31/381 , A61K31/40 , A61K31/44 , A61K31/5377 , A61P25/00 , C07D211/14 , C07D211/68 , C07D213/30 , C07D333/16 , C07D401/10
CPC classification number: C07D213/30 , C07D207/20 , C07D207/30 , C07D207/335 , C07D211/22 , C07D211/42 , C07D211/46 , C07D211/68 , C07D211/70 , C07D213/61 , C07D213/64 , C07D213/89 , C07D231/12 , C07D295/088 , C07D295/192 , C07D333/16 , C07D333/20 , C07D401/12 , C07D401/14 , C07D409/12 , C07D413/12
Abstract: The present patent application concerns compounds of formula (I) with R1 and R2 taken together with the nitrogen atom to which they are attached, form a mono or bicyclic saturated nitrogen-containing ring; their preparation and their use as a H3 receptor ligand for treating e.g. CNS disorders like Alzheimer's disease.
Abstract translation: 本发明涉及式(I)化合物,其中R1和R2与它们所连接的氮原子一起形成单或双环饱和含氮环; 它们的制备及其作为H3受体配体的用途,用于治疗例如 中枢神经系统疾病如阿尔茨海默病。
-
公开(公告)号:WO2006043149A2
公开(公告)日:2006-04-27
申请号:PCT/IB2005/003113
申请日:2005-10-18
Applicant: BIOPROJET , SUN PHARMACEUTICAL INDUSTRIES LTD , CAPET, Marc , LEVOIN, Nicolas , BERREBI-BERTRAND, Isabelle , POUPARDIN, Olivia , ROBERT, Philippe , SCHWARTZ, Jean-charles , LECOMTE, Jeanne-marie , RAJAMANNAR, Thennati , PAL, Ranjan Kumar , SAMANTA, Biswajit , JIVANI, Jignesh K , PANCHAL, Bhavesh M. , BHATT, Isha H. , ARADHYE, Jayraj D.
Inventor: CAPET, Marc , LEVOIN, Nicolas , BERREBI-BERTRAND, Isabelle , POUPARDIN, Olivia , ROBERT, Philippe , SCHWARTZ, Jean-charles , LECOMTE, Jeanne-marie , RAJAMANNAR, Thennati , PAL, Ranjan Kumar , SAMANTA, Biswajit , JIVANI, Jignesh K , PANCHAL, Bhavesh M. , BHATT, Isha H. , ARADHYE, Jayraj D.
CPC classification number: C07C237/24 , C07C229/30 , C07C229/48 , C07C323/12 , C07C2601/08
Abstract: The present patent application concerns new compounds of formula (I): displaying agonistic activity at sphingosine-1-phosphate (S1P) receptors, their process of preparation and their use as immunosuppressive agents.
Abstract translation: 本专利申请涉及式(I)的新化合物:在鞘氨醇-1-磷酸(S1P)受体显示激动活性,其制备方法及其作为免疫抑制剂的用途。
-
9.NOVEL PIPERIDINYL MONOCARBOXYLIC ACIDS AS S1P1 RECEPTOR AGONISTS 审中-公开
Title translation: 新型PIPERIDINYL单羧酸作为S1P1受体激动剂公开(公告)号:WO2012140020A1
公开(公告)日:2012-10-18
申请号:PCT/EP2012/056470
申请日:2012-04-10
Applicant: BIOPROJET , SUN PHARMA ADVANCED RESEARCH COMPANY LTD , CAPET, Marc , BERREBI-BERTRAND, Isabelle , ROBERT, Philippe , SCHWARTZ, Jean-Charles , LECOMTE, Jeanne-Marie , THENNATI, Rajamannar , PAL, Ranjan, Kumar , SAMANTA, Biswajit , PILLAI, Muthukumaran, Natarajan , DESAI, Japan, Nitinkumar , RANA, Dijixa, Chandubhai , PRAJAPATI, Kaushik, Dhanjubhai , PATHAK, Sandeep, Pankajbhai , PANCHAL, Bhavesh, M. , ARADHYE, Jayraj, D.
Inventor: CAPET, Marc , BERREBI-BERTRAND, Isabelle , ROBERT, Philippe , SCHWARTZ, Jean-Charles , LECOMTE, Jeanne-Marie , THENNATI, Rajamannar , PAL, Ranjan, Kumar , SAMANTA, Biswajit , PILLAI, Muthukumaran, Natarajan , DESAI, Japan, Nitinkumar , RANA, Dijixa, Chandubhai , PRAJAPATI, Kaushik, Dhanjubhai , PATHAK, Sandeep, Pankajbhai , PANCHAL, Bhavesh, M. , ARADHYE, Jayraj, D.
IPC: C07D413/10 , A61K31/454 , A61P9/10 , A61P29/00 , A61P37/06 , A61P35/00 , C07D413/14 , A61K31/5377
CPC classification number: C07D413/10 , A61K31/454 , A61K45/06 , C07D271/06
Abstract: The present invention relates to novel compounds acting as agonists at S1P (sphingosine-1-phosphate) receptors, compositions containing these compounds, use of these compounds in medicine and their process of preparation.
Abstract translation: 本发明涉及作为S1P(鞘氨醇-1-磷酸)受体的激动剂的新化合物,含有这些化合物的组合物,这些化合物在医药中的应用及其制备方法。
-
公开(公告)号:WO2006043149A9
公开(公告)日:2006-08-10
申请号:PCT/IB2005003113
申请日:2005-10-18
Applicant: BIOPROJET SOC CIV , SUN PHARMACEUTICAL IND LTD , CAPET MARC , LEVOIN NICOLAS , BERREBI-BERTRAND ISABELLE , POUPARDIN OLIVIA , ROBERT PHILIPPE , SCHWARTZ JEAN-CHARLES , LECOMTE JEANNE-MARIE , RAJAMANNAR THENNATI , PAL RANJAN KUMAR , SAMANTA BISWAJIT , JIVANI JIGNESH K , PANCHAL BHAVESH M , BHATT ISHA H , ARADHYE JAYRAJ D
Inventor: CAPET MARC , LEVOIN NICOLAS , BERREBI-BERTRAND ISABELLE , POUPARDIN OLIVIA , ROBERT PHILIPPE , SCHWARTZ JEAN-CHARLES , LECOMTE JEANNE-MARIE , RAJAMANNAR THENNATI , PAL RANJAN KUMAR , SAMANTA BISWAJIT , JIVANI JIGNESH K , PANCHAL BHAVESH M , BHATT ISHA H , ARADHYE JAYRAJ D
IPC: C07C229/30 , A61K31/10 , A61K31/165 , A61K31/196 , A61K31/197 , A61K31/216 , A61P37/06 , C07C229/48 , C07C237/24 , C07C323/12
CPC classification number: C07C237/24 , C07C229/30 , C07C229/48 , C07C323/12 , C07C2601/08
Abstract: The present patent application concerns new compounds of formula (I): displaying agonistic activity at sphingosine-1-phosphate (S1P) receptors, their process of preparation and their use as immunosuppressive agents.
Abstract translation: 本专利申请涉及式(I)的新化合物:显示对1-磷酸鞘氨醇(S1P)受体的激动活性,其制备过程及其作为免疫抑制剂的用途。
-
-
-
-
-
-
-
-
-